The regional legal schedule of occupational disease for the European Union: Annex I and Annex II of Commission Recommendation 2003/670/EC of 19 September 2003 concerning the European schedule of occupational diseases, **as amended**. This enum encodes the schedule in its **current consolidated form**, which is the version established by Commission Recommendation (EU) 2025/2609 of 18 December 2025. Two amendments have changed the schedule since 2003: - **Recommendation (EU) 2022/2337** (28 November 2022) added item **408**, COVID-19 contracted through work in disease prevention, health and social care and domiciliary assistance, or in a pandemic context in sectors with a proven outbreak risk. - **Recommendation (EU) 2025/2609** (18 December 2025) added four asbestos-related diseases to Annex I — **311** cancer of the larynx, **312** cancer of the ovary, **313** pleural plaques with functional impairment, and **314** non-malignant pleural effusion — and three suspected asbestos-related cancers to Annex II (**2.309** colon, **2.310** rectum, **2.311** stomach). In the same revision Annex II item 2.308 (cancer of the larynx following the inhalation of asbestos dust) was **removed**, having been promoted into Annex I as item 311; it is therefore not a permissible value here. Member States were asked to report implementation by 31 December 2026. Relationship to the ILO list. This schedule and the ILO list (``ILOCausativeAgentEnum`` / ``ILODiseaseCategoryEnum``) are separate instruments over the same subject matter and are **not** substitutes: the ILO list is the global tripartite consensus and is *biaxial*, organising section 2 by target organ system, which is why it takes two enums and two slots here. The European schedule is a regional instrument organised throughout by causative agent or route, so it is single-axis and takes one enum and one slot; it joins the ILO slots in the presentational ``occupational_classification`` slot group. The European schedule is also more specific in places the ILO list is generic — it names silicosis, asbestosis and mesothelioma as distinct items (301.11, 301.21, 301.22) where the ILO list has one fibrogenic-mineral-dust pneumoconiosis item (2.1.1) — and it uniquely carries COVID-19 and the asbestos additions above. Assign both when both apply; neither implies the other. Two tiers, and they mean different things: - **Annex I** is the recognised schedule. Member States are asked to introduce these diseases into national law; a listed disease linked directly to the occupation is liable for compensation and subject to prevention measures. - **Annex II** is the *additional list of diseases suspected of being occupational in origin* — notifiable, and candidates for later inclusion in Annex I. An Annex II assignment records a suspected, not established, occupational aetiology. Annex II keys are prefixed ``suspected_`` so the two tiers can never be confused at a glance, and an Annex II assignment must say so in ``notes``. Structure. Both annexes use the same five chapters (chemical agents; skin diseases; diseases caused by inhalation; infectious and parasitic diseases; physical agents), and items are numbered — Annex I ``100``-``508``, Annex II ``2.101``-``2.503``. Chapters 1 and 2.1 name *agents* rather than diseases, so an item there covers whatever disease that agent causes at work. Items 201 and 301 are themselves headers with numbered sub-items, and are encoded as intermediate nodes. The published numbering has genuine gaps (there is no 115.03, 134, 304.03, 305.02, 501, 2.131-2.139, 2.302 or 2.306) and, in two places, sub-items are printed out of numeric order (201.01/201.03/201.02/201.04, and 304.05/305.01/ 304.06). Both are faithfully reproduced: the gaps are simply absent, and item order follows the published text, not numeric sort. Do not "repair" either. Curation guidance for dismech: - Assign only when the disease is recognised as occupational in origin, on the same reasoning as the ILO enum — the schedule requires that the disease "must be linked directly to the occupation". - Record provenance in ``notes``: the item number, the annex, and the amendment that introduced it where it is one of the post-2003 additions. As with ICIMD and ISDS this is a definitional taxonomy mapping, not an empirical disease claim, so prefer ``notes`` over a manufactured evidence ``snippet``. - Item numbers are stable within the consolidated schedule and are what national law cites, so each is recorded verbatim at the head of its ``description``. Following the repo convention set by ``ISDSNosologyGroupEnum``, numbers are not part of any permissible-value key, so a future renumbering does not invalidate stored assignments. Sources: Commission Recommendation 2003/670/EC (OJ L 238, 25.9.2003, p. 28); Commission Recommendation (EU) 2022/2337 (OJ L 309, 30.11.2022); Commission Recommendation (EU) 2025/2609 (OJ L, 2025/2609). http://data.europa.eu/eli/reco/2003/670/oj